Karolina Akinosoglou | Infectious Diseases | Best Researcher Award

Posted on by sciencefather

Assist. Prof. Dr Karolina Akinosoglou | Infectious Diseases | Women Researcher Award

Assoc Prof, University of Patras, Greece

👩‍⚕️ Karolina-Anthoula Akinosoglou, born in Patra, Greece, on September 18, 1982, is a distinguished Associate Professor of Internal Medicine at the University of Patras. 🏥 She obtained her medical degree from the University of Patras (2006) and completed her PhD at Imperial College London (2011) specializing in Immunogenomics and Infection. 📚 Her clinical expertise spans infectious diseases, internal medicine, and tropical medicine, serving as a consultant at the University Hospital of Patras and a private maternity clinic. ✍️ Dr. Akinosoglou has published extensively with over 149 peer-reviewed journal articles and boasts a remarkable h-index of 35. 🎙️ She is a sought-after speaker at international conferences and an active member of several scientific societies. 🌍 Dr. Akinosoglou is also involved in mentoring postgraduate students and leads various research projects in infectious diseases, precision medicine, and epidemiology. 🏆 Her contributions have earned her numerous awards and recognition worldwide.

Profile

scopus

Education 🎓

Karolina-Anthoula Akinosoglou holds a Medical Degree (2000-2006) from the University of Patras and a PhD (2007-2011) from Imperial College London, where she specialized in Immunogenomics and Infection. 💉 She received postgraduate training at renowned institutions including St Mark’s and Northwick Park Hospital in London. 📖 Her academic journey reflects a commitment to bridging clinical practice with innovative research. 📚 Beyond her degrees, Dr. Akinosoglou has continuously enriched her expertise through various certifications and fellowships, including Good Clinical Practice (GCP). 🌟 She also leads educational programs in Precision Medicine, Epidemiology, Public Health, and Research Methodology at the University of Patras and the Hellenic Open University. 🏛️ Her extensive teaching portfolio spans undergraduate, postgraduate, and resident programs, emphasizing clinical skills, tropical medicine, and infectious diseases. 🌍 Dr. Akinosoglou’s educational background underpins her influential role in both clinical and academic medicine, shaping future healthcare leaders.

Experience 🏥

Karolina-Anthoula Akinosoglou began her medical career in Infection and Tropical Medicine at St Mark’s and Northwick Park Hospital (2008-2010). 🩺 She then joined the University Hospital of Patras (2010-today), advancing from Internal Medicine Resident to Associate Professor and Consultant in Infectious Diseases. 🌟 She led the hospital’s COVID-19 ward and post-COVID clinic (2020-2022) and is currently an Infectious Diseases Consultant at a private maternity clinic. 🌍 Dr. Akinosoglou has trained numerous residents and led postgraduate courses in Tropical Medicine, Respiratory Failure, and Clinical Epidemiology. 🧪 She is also a Principal Investigator in multiple clinical trials and supervises doctoral and master’s theses. 📚 Her involvement extends to university and hospital committees, focusing on ethics, quality assessment, and infection control. 🏆 With over a decade of leadership in clinical care, research, and education, Dr. Akinosoglou is a pillar of modern Greek medicine.

Awards and Honors 🏆

Karolina-Anthoula Akinosoglou has been recognized with numerous prestigious awards for her contributions to medicine and research. ✈️ She received the Leventis Foundation Scholarship for postgraduate studies (2007-2010) and multiple Young Investigator Travel Awards from ISAC, ESCMID, and EACS. 🌍 Her achievements include the Sotiris Papastamatis Prize for abstract merit (2017, 2022-2024) and scholarships for HIV Summer Schools and Infectious Diseases Fellow Programs. 🎖️ In 2023, she won the 3rd Prize at the 20th European Shock Society Congress and was listed in Stanford/Elsevier’s Top 2% Scientists Rankings. 📚 Dr. Akinosoglou’s consistent excellence in research and clinical practice has earned her numerous travel grants and conference scholarships from leading organizations like Gilead, ASM, and ISHEID. 🥇 Her accolades underline her dedication to advancing internal medicine and infectious diseases on both national and international levels.

Research Focus 🔬

Karolina-Anthoula Akinosoglou specializes in infectious diseases, internal medicine, and tropical medicine with a focus on HIV, HBV, HDV, HEV, and sepsis. 🧪 She has led groundbreaking research in platelet activation, regulatory T-cells in HIV, and viral co-infections in Greece. 💉 Her work is supported by major grants from organizations like Gilead and the Hellenic Institute for Sepsis, with notable studies such as PRESS, Asklepios, and Karatheodoris projects. 🌍 As a Principal Investigator and Sub-Investigator in over 30 multicenter clinical trials, she emphasizes precision medicine, epidemiology, and public health. 📊 Dr. Akinosoglou’s contributions include guideline development for the Hellenic Society of Infectious Diseases and obstetric infections. 📚 She actively publishes in top journals, focusing on antimicrobial resistance, sepsis, and emerging infections, making her a key figure in global infectious disease research. 🩺 Her innovative approach bridges clinical care and translational science.

Publications Top Notes📚
  • Transitions of blood immune endotypes and improved outcome by anakinra in COVID-19 pneumonia: an analysis of the SAVE-MORE randomized controlled trial
    • Authors: Kyriazopoulou, E., Hasin-Brumshtein, Y., Midic, U., et al.
    • Journal: Critical Care, 2024, 28(1), 73
    • Citations: 4
    • Overview: The article investigates immune changes in blood during COVID-19 pneumonia and examines how anakinra impacts clinical outcomes.
  • qSOFA combined with suPAR for early risk detection and guidance of antibiotic treatment in the emergency department: a randomized controlled trial
    • Authors: Adami, M.E., Kotsaki, A., Antonakos, N., et al.
    • Journal: Critical Care, 2024, 28(1)
    • Citations: 7
    • Overview: This trial combines qSOFA scores and suPAR levels to assess early risk and guide antibiotic use in emergency settings.
  • Global, regional, and national stillbirths at 20 weeks’ gestation or longer in 204 countries and territories, 1990–2021: findings from the Global Burden of Disease Study 2021
    • Authors: Comfort, H., McHugh, T.A., Schumacher, A.E., et al.
    • Journal: The Lancet, 2024, 404(10466), pp. 1955–1988
    • Citations: 1
    • Overview: The study presents a comprehensive analysis of stillbirth data globally over the past three decades, examining trends and disparities.
  • Prolactin Role in COVID-19 and Its Association with the Underlying Inflammatory Response
    • Authors: Polyzou, E., Schinas, G., Bountouris, P., et al.
    • Journal: International Journal of Molecular Sciences, 2024, 25(22), 11905
    • Citations: 0
    • Overview: This article explores how prolactin levels in COVID-19 patients correlate with inflammatory responses and disease progression.
  • Modulation of Metabolomic Profile in Sepsis According to the State of Immune Activation
    • Authors: Kranidioti, E., Ricaño-Ponce, I., Antonakos, N., et al.
    • Journal: Critical Care Medicine, 2024, 52(11), pp. e536–e544
    • Citations: 0
    • Overview: The study investigates how metabolomic profiles in sepsis are affected by immune activation status, providing insights into sepsis management.
  • Antiviral therapy for patients with COVID-19: mix and match
    • Authors: Akinosoglou, K., Gogos, C.
    • Journal: The Lancet Infectious Diseases, 2024, 24(11), pp. 1179–1181
    • Citations: 0
    • Overview: This article reviews antiviral therapies for COVID-19, focusing on combination treatments to improve patient outcomes.
  • Rapid Molecular Diagnostics in Vulvovaginal Candidosis
    • Authors: Akinosoglou, K., Schinas, G., Papageorgiou, D., et al.
    • Journal: Diagnostics, 2024, 14(20), 2313
    • Citations: 0
    • Overview: A review of the use of rapid molecular diagnostics in diagnosing vulvovaginal candidosis, aiming for faster and more accurate treatments.
  • Mpox and Lessons Learned in the Light of the Recent Outbreak: A Narrative Review
    • Authors: Protopapas, K., Dimopoulou, D., Kalesis, N., et al.
    • Journal: Viruses, 2024, 16(10), 1620
    • Citations: 0
    • Overview: This review assesses the recent Mpox outbreak, drawing lessons to better manage future outbreaks.
  • Treatment Management Challenges in Naïve and Experienced HIV-1-Infected Individuals Carrying the M184V Mutation
    • Authors: Mimtsoudis, I., Tsachouridou, O., Akinosoglou, K., et al.
    • Journal: Viruses, 2024, 16(9), 1392
    • Citations: 0
    • Overview: The article discusses the challenges in treating HIV-1-infected patients, especially those with the M184V mutation, which affects drug resistance.
  • Probiotics in the Management of Vulvovaginal Candidosis
    • Authors: Akinosoglou, K., Schinas, G., Polyzou, E., et al.
    • Journal: Journal of Clinical Medicine, 2024, 13(17), 5163
    • Citations: 0
    • Overview: This review examines the role of probiotics in treating vulvovaginal candidosis and its potential as an alternative or adjunct therapy.

Conclusion

Dr. Karolina-Anthoula Akinosoglou’s qualifications and contributions position her as an outstanding candidate for the Research for Best Researcher Award. Her combination of academic excellence, leadership in both clinical and academic settings, and high-impact research contributions in infectious diseases makes her a formidable force in the field of global healthcare. With minor improvements in interdisciplinary research and public engagement, she has the potential to amplify the impact of her work, making her highly deserving of this prestigious recognition.

Joseph Stancanello | Medical | Excellence in Innovation

Posted on by sciencefather

Dr. Joseph Stancanello | Medical | Excellence in Innovation

Vicepresident, Elekta, France

Joseph Stancanello (b. 09/03/1976) is a global healthcare technology leader with a Ph.D. in Bioengineering from Politecnico di Milano. 🌍 With executive roles across top medical companies like Elekta, Guerbet, and Siemens Healthcare, he has driven innovation in radiotherapy and imaging systems. ✨ An expert in P&L management, business development, and R&D, Joseph bridges clinical, regulatory, and business needs. He excels in defining value propositions and fostering innovation through strategic partnerships and mergers. 💡 Beyond his corporate impact, he reviews cancer research proposals for European TRANSCAN calls and AI funding for the Italian Ministry of Research. 🧠 His expertise spans AI, radiotherapy, and advanced imaging technologies, addressing both patient care and market growth.

Publication Profile

scopus

Education🎓

Joseph Stancanello has a Ph.D. in Bioengineering and an MSc in Biomedical Engineering, both magna cum laude from Politecnico di Milano. 🌟 He also earned an Executive MBA from MIP Politecnico di Milano, securing the 2010 Best Dissertation Prize. 🎖️ His educational foundation includes:  Executive education at INSEAD, SDA Bocconi, and MIT-Sloan School of Management.  Specialized programs like “Finance for Executives” and “Driving Strategic Innovation. nA classical education background from “Secusio” Liceo in Italy (60/60). Joseph combines technical expertise with business acumen, driving healthcare innovation globally.

Experience 🌍

Joseph Stancanello has over two decades of global healthcare experience: VP Clinical Applications, Elekta (2021–Present): Leads global teams in advancing radiotherapy imaging and therapy solutions. Director of Marketing AI, Guerbet (2019–2021): Launched AI-based cancer diagnostics solutions. CEO, Oncoradiomics (2017–2019): Managed VC fundraising and global business strategies. Leadership roles at GE and Siemens (2007–2015): Spearheaded MRI research, workflows, and innovative imaging techniques.

Awards & Honors🏆 

Joseph Stancanello has received multiple accolades for his contributions to healthcare: Best Dissertation Prize, Politecnico di Milano Executive MBA, 2010. Invited reviewer for European TRANSCAN cancer calls and AI projects (2022–2024). Recognized for advancing imaging systems and radiotherapy applications globally.
These achievements underscore his leadership in healthcare technology and research.

Research Focus 🌟

Advanced radiotherapy techniques and imaging for cancer care. 📊 AI in healthcare, focusing on diagnostic and predictive tools  Morphological and functional imaging in radiosurgery. Bridging clinical needs with technology innovations to improve patient outcomes His research drives precision medicine and healthcare transformation globally.

Publications

  • Evolution of AI in Medical Imaging: The review by Avanzo et al. (2024) emphasizes the integration of computer science principles with machine and deep learning techniques to enhance medical imaging applications.
  • Head and Neck Cancer Prognosis: Studies by Wang et al. (2022) and Lombardo et al. (2021) develop convolutional neural network (CNN)-based models for predicting cancer prognosis and metastasis, demonstrating the potential of AI in clinical oncology.
  • Radiomics and Deep Learning: The series of works, including a review in Strahlentherapie und Onkologie (2020), explore how combining radiomics and deep learning improves tumor response prediction and radiotherapy outcomes.
  • Lung Cancer and Radiomics: Multiple studies, including Avanzo et al. (2021), utilize CT imaging and biologically effective dose data in radiomics to enhance predictive models for robotic lung stereotactic radiation therapy.
  • Fibrosis and Dosimetry: Avanzo and colleagues (2020) focus on using machine learning to predict radiation-induced fibrosis, advancing personalized medicine approaches in radiotherapy.
  • AI in Hybrid Imaging: Castiglioni et al. (2019) detail how AI-based tools in hybrid imaging facilitate multi-parametric decision-making, underscoring the versatility of AI in various imaging modalities.
  • Practical Applications in IOERT: Research on intraoperative electron radiotherapy (Avanzo et al., 2020) addresses dosimetry challenges and tissue inhomogeneities, bridging AI with practical clinical applications.
  • Clinical Trials in Breast Cancer: Long-term outcomes of partial breast irradiation trials (Vinante et al., 2019) highlight advancements in treatment protocols facilitated by AI-enhanced imaging analysis.

Conclusion

Dr. Joseph Stancanello’s exemplary leadership in medical imaging, AI-driven solutions, and radiotherapy innovation makes him an ideal candidate for the Research for Excellence in Innovation Award. His ability to bridge technical expertise with strategic foresight has significantly influenced global healthcare innovation. Continued efforts to expand his publication record and integrate broader societal benefits into his projects would further enhance his profile. This evaluation underscores his readiness to receive this recognition as a pioneer in healthcare innovation.